C57BL/6 mice (10 per group) were challenged subcutaneously on the right limb with 0.1x10 LLC cells. Mice were divided into three groups and locally irradiated with the radiation dosage (12, 16.8 or 24 Gy) applied in equal doses on three consecutive days starting on day 15.
C57BL/6 mice (n = 4 per group) were challenged s.c. on the right hind limb with 5x10 5 3LL-GFP cells. 18 days after tumor challenge mice were treated with local radiation alone (36 Gy total, divided into 3 equal fractions on 3 consecutive days) (RTX alone), vaccination alone (32µg, twice a week, started at day 18) (RNA alone) or with radioimmunotherapy (with first vaccination given on day 19) (RNA+RTX Mice were treated as described in the figure legend to Figure 3 of the main manuscript and the gating strategy to identify DCs is shown. Cells were first gated on single cells to exclude doublets, follow by live/dead staining and CD45.2 staining for lymphocytes. DCs were characterized as CD11c + within lymphocyte gate (CD45.2 + ) (including CD8 + and CD8 -cells) (as depicted by the rectangular box).
